Invest Now
Samco Star Rating Ads

Sun Pharma Advanced Research Company Ltd Price Performance

  • Day's Low
  • ₹216.15
  • Day's High
  • ₹224
₹ 218
  • 52-w low
  • ₹189.75
  • 52-w high
  • ₹472.8
218
  • Day's open
    ₹222.66
  • Previous close
    ₹223.320007
  • VWAP
    ₹219.83
  • Lower price band
    ₹178.65
  • Upper price band
    ₹267.98

Today's Market Action

The last traded share price of Sun Pharma Advanced Research Company Ltd was 218.00 down by -2.38% on the NSE. Its last traded stock price on BSE was 218.10 down by -2.33%. The total volume of shares on NSE and BSE combined was 1,434,955 shares. Its total combined turnover was Rs 31.54 crores.

Sun Pharma Advanced Research Company Ltd Medium and Long Term Market Action

Sun Pharma Advanced Research Company Ltd hit a 52-week high of 472.8 on 09-04-2024 and a 52-week low of 189.75 on 21-11-2024. The stock price of Sun Pharma Advanced Research Company Ltd is up by 13% over the last one month. It is down by -18.67% over the last one year. Don't forget to check the full stock price history in the table below.

Sun Pharma Advanced Research Company Ltd Fundamentals

  • Market Cap (Cr): 6405

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Sun Pharma Advanced Research Company Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Sun Pharma Advanced Research Company Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Sun Pharma Advanced Research Company Ltd

Data not available.

Sun Pharma Advanced Research Company Ltd FAQ's

What is Share Price of Sun Pharma Advanced Research Company Ltd?

What is the Market Cap of Sun Pharma Advanced Research Company Ltd?

What is PE Ratio of Sun Pharma Advanced Research Company Ltd?

What is PB Ratio of Sun Pharma Advanced Research Company Ltd?

What is the CAGR of Sun Pharma Advanced Research Company Ltd?

How to Buy Sun Pharma Advanced Research Company Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • No Data Available

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Negative operating earnings and interest coverage
    The company has a negative operating earnings and a negative Interest coverage ratio of -202.00 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.73. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(19/12/2024)
Stock Valuation
Green line
105
100.00%
100.00% People are bullish about Sun Pharma Advanced Research Company Ltd
0.00%
0.00 % People are bearish about Sun Pharma Advanced Research Company Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Sun Pharma Advanced Research Company Ltd

218.00 -5.32 (-2.38%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91